EX-23.1 4 e618283_ex23-1.htm

 

Exhibit 23.1

 

Consent of Independent Registered 

Public Accounting Firm

 

We consent to the incorporation by reference in the registration statements on Form S-8 (File Nos. 333-229921, 333-224492, 333-220058, 333-204590, and 333-193635) and Form S-3 (File Nos. 333-225048 and 333-218802) of our report, which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, dated March 13, 2019 with respect to the consolidated financial statements of ADMA Biologics, Inc. and subsidiaries as of December 31, 2018 and 2017 and for the years then ended and our report dated March 13, 2019 with respect to the effectiveness of internal control over financial reporting of ADMA Biologics, Inc. and subsidiaries as of December 31, 2018, included in this Annual Report on Form 10-K of ADMA Biologics, Inc. for the year ended December 31, 2018.

 

/s/ CohnReznick LLP

 

Roseland, New Jersey

 

March 13, 2019